Hannah L. Woodward

UCL Biomedical Research Centre — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index658citations58works7.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microtubule and mitosis dynamics(19), Ubiquitin and proteasome pathways(12), Cancer Genomics and Diagnostics(9), Protease and Inhibitor Mechanisms(7), Cancer-related Molecular Pathways(5)

Publications55 total

P-1793. Consensus Guidelines for the Clinical Validation and Interpretation of Respiratory Metagenomic Data from the UK National Health Service Respiratory Metagenomics Network
Open Forum Infectious Diseases·2026Open Access
Primary Small Intestinal Epithelia Are Physiological Alternatives to the Caco-2 Lymphatic Transport Model
Molecular Pharmaceutics·2025· 1 cited
COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People
JAMA Psychiatry·2024· 19 citedOpen Access
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform
EClinicalMedicine·2023· 6 citedOpen Access
Supplementary Table S3 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S2 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Table S1 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S1 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Table S2 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S1 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Table S3 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Table S2 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Data from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S4 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S3 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S3 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S4 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figure S2 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Supplementary Table S1 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
Data from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Swen Hoelder(25), Paolo Innocenti(24), Angela Hayes(23), Rosemary Burke(23), Florence I. Raynaud(23), Amir Faisal(21), Julian Blagg(21), Suzanne A. Eccles(21), Spiros Linardopoulos(21), Isaac M. Westwood(20), Grace Wing-Yan Mak(19), Sébastien Naud(19), Rob L. M. van Montfort(18), Harry Saville(18), Mark D. Gurden(16), Simon Anderhub(15), Katie Walsh(15), Κωνσταντίνος Δροσόπουλος(13), Efthymia Theofani(13), Simone Filosto(13)